Dulaglutide improves glucocorticoid-induced hyperglycemia in inpatient care and reduces dose and injection frequency of insulin

摘要

Changes in GC dose and body weight at pretreatment and discharge. Timing of data collection, and treatment course of non-Dula and Dula groups in this study. GC maintenance dose at pretreatment and discharge, and ( ) cumulative GC dose during the observation. Bodyweight changes at pretreatment and discharge. Data are expressed as Tukey’s box-and-whisker plots. Pre, pretreatment. GC, glucocorticoid. *** < 0.001 vs. pretreatment of the same group.